-
August 22, 2018 Lupin receives tentative FDA approval for generic Nudovra (Estradiol Valerate Tablets, 3 mg and 1 mg and Estradiol Valerate and Dienogest Tablets, 2 mg/2 mg and 2 mg/3 mg) Tablets
-
August 21, 2018 Lupin receives FDA approval for generic Hydrocortisone Butyrate Lotion, 0.1%
-
August 21, 2018 Lupin launches generic Clobetasol Propionate Cream USP 0.05% in the US
-
August 8, 2018 Quarter I, FY2019 – Results
-
July 30, 2018 Lupin’s Mandideep facility gets approval from EDQM
-
July 27, 2018 Lupin launches generic Desoximetasone Topical Spray, 0.25% in the US
-
July 24, 2018 Lupin receives FDA approval for Fluocinonide Topical Solution
-
July 19, 2018 Lupin receives tentative FDA approval for generic Tadalafil Tablets USP, 2.5 mg, 5 mg, 10 mg, and 20 mg
-
July 16, 2018 Lupin’s Goa facility gets approval from UK MHRA
In this section
Media Contacts
-
Rajalakshmi Azariah
Vice President & Global Head – Corporate Communications